Bryan Johnson: new peptide experiment, results coming soon

ByLongevity Notes Editorial
🟢
Peer-Reviewed Research
B
Bryan Johnson

Video Summary · May 5, 2026

View Full Protocol →

Key Takeaways

  • Tirzepatide and CJC-1295 DAC are being tested in combination to cancel out side effects while retaining benefits.
  • Tirzepatide improves metabolic function but may raise heart rate and disrupt sleep.
  • CJC-1295 DAC boosts growth hormone/IGF-1 for repair but may cause insulin resistance.
  • 4-week protocol with escalating doses, tracked via weekly blood tests, continuous glucose monitoring, and sleep metrics.

Supplements & Protocols Mentioned

  • Tirzepatide: Metabolic optimization peptide (dose increasing weekly).
  • CJC-1295 DAC: Growth hormone-stimulating peptide (dose increasing weekly).

Notable Quotes

“Peptides and I have a complicated relationship, but we are giving it another shot.”

Bottom Line

Experimenting with peptide stacking to balance side effects—track results through rigorous biomarker testing before considering similar protocols.

Explore supplements mentioned in this video

Shop on iHerb →

Explore More

Watch the Full Video

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.

⚡ Research Insider Weekly

Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.

No spam. Unsubscribe anytime. Powered by Beehiiv.

From Our Research Network

Part of the Evidence-Based Research Network

Similar Posts